Chris Evert announces ovarian cancer recurrence, will miss Wimbledon

Chris Evert faces a recurrence of ovarian cancer requiring surgery and chemotherapy, impacting her professional commitments and quality of life.
Ovarian cancer is relentless, but I will stay optimistic
Evert's statement as she announced her cancer recurrence and withdrawal from professional duties.

Chris Evert, whose grace and precision redefined women's tennis across two decades, now faces a renewed battle with a disease as relentless as any opponent she has met on court. The 18-time Grand Slam champion announced Thursday that her ovarian cancer has recurred, requiring surgery already completed and chemotherapy ahead, drawing her away from Wimbledon and the professional world she has continued to shape as a commentator. In choosing transparency over silence, Evert extends into illness the same unflinching resolve that once made her the world's top-ranked player for five unbroken years — a reminder that the most defining contests are not always played on grass or clay.

  • Imaging scans taken over the weekend confirmed what Evert and those close to her must have feared: the cancer she believed she had defeated has returned, and the fight must begin again.
  • Surgery has already been performed, compressing the timeline of crisis into days rather than weeks, with chemotherapy set to follow in the coming weeks.
  • Wimbledon — where Evert has been a familiar and authoritative voice in the broadcast booth — will open next week without her, a visible absence that signals the seriousness of her withdrawal from public life.
  • Evert's own words carry the weight of someone who understands the statistics: roughly seven in ten ovarian cancer patients face recurrence, and she is now navigating that reality for the second time.
  • Rather than retreat into privacy, she has chosen openness, framing her public disclosure as both personal truth-telling and a continued act of advocacy for a disease that too often goes undetected until it is advanced.

Chris Evert announced Thursday that her ovarian cancer has returned. The news came after CT and PET scans performed over the weekend revealed the recurrence, and she had already undergone surgery by the time she shared the update publicly. Chemotherapy is planned for the weeks ahead.

Evert's place in tennis history is singular. An 18-time Grand Slam champion, she held the world's number-one ranking for 260 consecutive weeks after the WTA began tracking rankings in 1975, and the association credits her with transforming the sport through her backhand technique. In recent years she has remained a prominent presence at the sport's major events as a broadcast commentator.

That presence will be absent from Wimbledon, which begins next week. She is also stepping back from other professional commitments for the foreseeable future, making treatment and recovery her sole focus in the months ahead.

Evert was first diagnosed in December 2021. She announced the cancer had been cleared in January 2023, only for it to return by the end of that same year. This latest recurrence marks the second time the disease has come back. In her announcement, she wrote that ovarian cancer is relentless, but pledged to remain optimistic and determined — a tone that was honest about the gravity of what she faces without surrendering to it.

The Ovarian Cancer Research Alliance estimates that roughly seven in ten patients will experience a recurrence at some point, underscoring the disease's stubborn and aggressive nature. Evert's willingness to speak openly about each stage of her illness has added a dimension of public advocacy to a life already defined by breaking barriers.

Chris Evert announced Thursday that her ovarian cancer had returned. The tennis legend shared the news through social media, explaining that imaging scans performed over the weekend—a CT scan and a PET scan—had revealed the recurrence. She had already undergone surgery, which she described as the opening move in her renewed fight against the disease. Chemotherapy would follow in the coming weeks.

Evert, an 18-time Grand Slam champion, has long been regarded as one of tennis's most transformative figures. The Women's Tennis Association credits her with revolutionizing the sport through her backhand technique. She held the world's number-one ranking for 260 consecutive weeks after the WTA began tracking rankings in 1975—a span that speaks to the consistency and dominance that defined her career.

The recurrence forces her to step away from professional life for the foreseeable future. She will not be traveling to London for Wimbledon, where she has regularly appeared as a broadcast commentator. The Championships begin next week. Beyond that single absence, she is withdrawing from other work commitments as well, prioritizing treatment and recovery over the next several months.

In her announcement, Evert emphasized her commitment to transparency about her health. "Ovarian cancer is relentless," she wrote, "but I will stay optimistic and determined in continuing to fight this battle." The tone was resolute without minimizing the gravity of what she faces.

Evert was first diagnosed with ovarian cancer in December 2021. In January 2023, she announced that the cancer had been cleared—a moment of relief that proved temporary. By December of that year, the disease had returned. Now, less than a year later, she is managing a second recurrence.

The statistics underscore why her determination matters. According to the Ovarian Cancer Research Alliance, roughly seven in ten patients who have ovarian cancer will experience a recurrence at some point. The disease's tendency to return, even after successful initial treatment, makes it one of the most challenging cancers to manage long-term. Evert's public disclosure of her recurrence, and her continued willingness to speak openly about her treatment, adds another chapter to a career already defined by breaking barriers and setting new standards.

I have always believed in being open and honest about my health journey. This past weekend, after undergoing CT and PET scans, I learned that my ovarian cancer has returned.
— Chris Evert, in her social media announcement
Ovarian cancer is relentless, but I will stay optimistic and determined in continuing to fight this battle.
— Chris Evert
The Hearth Conversation Another angle on the story
Inventor

When someone like Chris Evert steps back from public life, what does that actually mean for her day-to-day?

Model

It means no travel, no commentary booths, no professional obligations. Just the medical appointments, the infusions, the recovery time. For someone whose entire adult life has been structured around tennis, that's a profound shift.

Inventor

She's had this cancer before. Does a recurrence feel different than the initial diagnosis?

Model

Psychologically, yes. The first time, there's shock and uncertainty. The second time, you know what's coming—the side effects, the timeline, the fear. But you also know you've survived it once.

Inventor

Why do you think she announced this publicly rather than quietly stepping back?

Model

She said it herself—she believes in being open about her health journey. But there's also something else: silence around cancer can feel like shame. By naming it, she's refusing that.

Inventor

The statistic about 70% recurrence rates is sobering. Does that change how we should think about her prognosis?

Model

It contextualizes her fight. She's not an outlier. She's one of many people managing a disease that doesn't stay gone. That's why her determination matters—not because she's special, but because she's representative.

Inventor

What happens to Wimbledon without her commentary?

Model

The broadcast goes on. But there's an absence. She's been part of that tradition for years. Her voice carries weight because she lived the game at the highest level.

Inventor

Do you think she'll return to commentary eventually?

Model

That depends entirely on how treatment goes. She's not ruling it out—she's just being realistic about what her body needs right now.

Contact Us FAQ